{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-14T12:22:22.466373+00:00",
  "news": [
    {
      "title": "Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPdzduVzR5YzE1Mmh0YjYxMHBKY1lfb04zeGl6dFVudmdwUHh2cXFLQWM5Um5EMVM2blpJM2hzbjNFV0NIM190X29iczMteFJFVk9iMDlMb2prSGdLZWZpQ2NMRG5SOF9vdW84b0FoYXN3RHQ0UllVN3Z2NThCOTZkV3d2UlBtRmRsNDRTLTg1WVNnejdSWklnUUk3MnIyVHRaanR1TEhINGtmMjZPX2hwV05XM2RMeHlpcFJWOWVR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPdzduVzR5YzE1Mmh0YjYxMHBKY1lfb04zeGl6dFVudmdwUHh2cXFLQWM5Um5EMVM2blpJM2hzbjNFV0NIM190X29iczMteFJFVk9iMDlMb2prSGdLZWZpQ2NMRG5SOF9vdW84b0FoYXN3RHQ0UllVN3Z2NThCOTZkV3d2UlBtRmRsNDRTLTg1WVNnejdSWklnUUk3MnIyVHRaanR1TEhINGtmMjZPX2hwV05XM2RMeHlpcFJWOWVR?oc=5\" target=\"_blank\">Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-12-11T15:40:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5\" target=\"_blank\">Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-05T08:00:00+00:00",
      "source": "Amgen"
    },
    {
      "title": "Rexford Capital Inc. Purchases New Shares in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOXJIZ2JLWTR3RlFHQzBuSEt5NW1nTGhPT2pURlIwZmpQSi1zWFJMbGN2MTlpb04wdzZvdk5RSnYyWjBtTHV5Zk1YQk5KZFd0Q0xGOHF6WUcyNmdwNWIxcV9HcUJYQ2NiUXdsc2Rnc0dZYTdpOWRmMFFOWGUzUzNrZTJ1WHVNdU1tT3FHX2xaZDc4S2VMVHIxSEQ2T2FvT1FBU0t5ODNMRkpTT3VNZGRGNkhvRnpZY2NPLWdN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPOXJIZ2JLWTR3RlFHQzBuSEt5NW1nTGhPT2pURlIwZmpQSi1zWFJMbGN2MTlpb04wdzZvdk5RSnYyWjBtTHV5Zk1YQk5KZFd0Q0xGOHF6WUcyNmdwNWIxcV9HcUJYQ2NiUXdsc2Rnc0dZYTdpOWRmMFFOWGUzUzNrZTJ1WHVNdU1tT3FHX2xaZDc4S2VMVHIxSEQ2T2FvT1FBU0t5ODNMRkpTT3VNZGRGNkhvRnpZY2NPLWdN?oc=5\" target=\"_blank\">Rexford Capital Inc. Purchases New Shares in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-14T11:00:51+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOVXotQVpvZEJLWFBSR0NQTjBTM0Y5YkROLTFlaXFDcThNN0owMFo5dGwtNnBkenVrcWpTVlZ2c1hZRkJaRzlzX1AzZ3hLVHlNQWtSN0FhdnZWX1lremVjd1lxOFMyQUt0NGFtQjhKNnpkWEtKeFNiQnlzOUZtczB6b0dGTVdHd05ua3E4SV94MGVMTlZvem82WVFfOGZKRWp2?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMioAFBVV95cUxOVXotQVpvZEJLWFBSR0NQTjBTM0Y5YkROLTFlaXFDcThNN0owMFo5dGwtNnBkenVrcWpTVlZ2c1hZRkJaRzlzX1AzZ3hLVHlNQWtSN0FhdnZWX1lremVjd1lxOFMyQUt0NGFtQjhKNnpkWEtKeFNiQnlzOUZtczB6b0dGTVdHd05ua3E4SV94MGVMTlZvem82WVFfOGZKRWp2?oc=5\" target=\"_blank\">AMGEN ANNOUNCES 2026 FIRST QUARTER DIVIDEND</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-12-09T21:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Amgen wins FDA approval for Uplizna in generalized myasthenia gravis - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxQcWJzZjZDUWcxSXdLbFhFNDItRG0zZjBMSU9FWjVCZjZQVTcwYy15QWllNk15SEpUay1RRmVDbFV6VGx2V3NzLW40cTYybjNFakpPZDdVWmxXeklBOE0wUjdzMXFjME1mdV9kMTVSRnZBUHhla1lXcFl0WG5DN1N0TEF1aFV4MFllN005V0paZTVNbk0yNHJYZ2JiMGFVNkt0Qlkya1kwS3NpdTFxVHJONUY3WDJPZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxQcWJzZjZDUWcxSXdLbFhFNDItRG0zZjBMSU9FWjVCZjZQVTcwYy15QWllNk15SEpUay1RRmVDbFV6VGx2V3NzLW40cTYybjNFakpPZDdVWmxXeklBOE0wUjdzMXFjME1mdV9kMTVSRnZBUHhla1lXcFl0WG5DN1N0TEF1aFV4MFllN005V0paZTVNbk0yNHJYZ2JiMGFVNkt0Qlkya1kwS3NpdTFxVHJONUY3WDJPZw?oc=5\" target=\"_blank\">Amgen wins FDA approval for Uplizna in generalized myasthenia gravis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-12-12T10:22:05+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "How Amgen Combines Life-Saving Biotech & Sustainability - Healthcare Digital",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxQUTJZY2ppbnV6ZEd6UGlSZTNTWjVpOXlFUEE0Qk1BdHJKbW03MmhnY1Q3VDEtUkczZjExTl9qbURMMXB5RnA2OXhZN1AwY01WN0p5eGcxUEY2S3NqSjFOOU92bmdWT1hkLVM5RUJKSEdSLWpZMmVkRjRha0Q0TnFhdXdZU2Jyb29DU1ZFMlN0Z1I5Mzg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxQUTJZY2ppbnV6ZEd6UGlSZTNTWjVpOXlFUEE0Qk1BdHJKbW03MmhnY1Q3VDEtUkczZjExTl9qbURMMXB5RnA2OXhZN1AwY01WN0p5eGcxUEY2S3NqSjFOOU92bmdWT1hkLVM5RUJKSEdSLWpZMmVkRjRha0Q0TnFhdXdZU2Jyb29DU1ZFMlN0Z1I5Mzg?oc=5\" target=\"_blank\">How Amgen Combines Life-Saving Biotech & Sustainability</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Healthcare Digital</font>",
      "published": "2025-12-10T17:29:14+00:00",
      "source": "Healthcare Digital"
    },
    {
      "title": "Amgen's Uplizna wins sought-after gMG approval in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hREE1b000cGFPSF9UdTRWYmJuaFpZNERDc1B6Qm5JMGk3U1B2SEpKbkxGUzE2UjR6d2xXTXNKUGRLZnlMUGVoano0bUxSR1FNVjg0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1hREE1b000cGFPSF9UdTRWYmJuaFpZNERDc1B6Qm5JMGk3U1B2SEpKbkxGUzE2UjR6d2xXTXNKUGRLZnlMUGVoano0bUxSR1FNVjg0?oc=5\" target=\"_blank\">Amgen's Uplizna wins sought-after gMG approval in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-12-11T16:27:10+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies - PharmExec.com",
      "link": "https://news.google.com/rss/articles/CBMikgFBVV95cUxNbGhmdDN6LU5oZTNHYUVqb2drUlFVV0dNaFU1TklvaWhxQXhoV0pQWXhFU01HaTBFU0w5S3lVUGdmSWdpVGpRUzR2X0JNSHp4QjNkLWI0UEFHTjMyMFdiT0RLclUtVVJ1bHBLbzBTZWhZSzEydzF0T3c1ODI4Zk4tV2lkZHdCLVV0SVJUN3FTc2M5Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikgFBVV95cUxNbGhmdDN6LU5oZTNHYUVqb2drUlFVV0dNaFU1TklvaWhxQXhoV0pQWXhFU01HaTBFU0w5S3lVUGdmSWdpVGpRUzR2X0JNSHp4QjNkLWI0UEFHTjMyMFdiT0RLclUtVVJ1bHBLbzBTZWhZSzEydzF0T3c1ODI4Zk4tV2lkZHdCLVV0SVJUN3FTc2M5Zw?oc=5\" target=\"_blank\">FDA Approves Amgen's Uplizna for Generalized Myasthenia Gravis With Positive AChR or MuSK Antibodies</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmExec.com</font>",
      "published": "2025-12-12T16:04:38+00:00",
      "source": "PharmExec.com"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - Pharma Voice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Pharma Voice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "Pharma Voice"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-12",
      "close": 317.739990234375
    },
    "history": [
      {
        "date": "2025-12-04",
        "close": 340.1600036621094
      },
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      },
      {
        "date": "2025-12-08",
        "close": 321.2300109863281
      },
      {
        "date": "2025-12-09",
        "close": 313.8500061035156
      },
      {
        "date": "2025-12-10",
        "close": 315.3800048828125
      },
      {
        "date": "2025-12-11",
        "close": 317.3800048828125
      },
      {
        "date": "2025-12-12",
        "close": 317.739990234375
      }
    ],
    "name": "Amgen Inc."
  }
}